Patents by Inventor Raphaele Le Garrec

Raphaele Le Garrec has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Protease-activated receptor-2 inhibitors for the treatment of sensory neuropathy induced by a marine neurotoxic poisoning
    Patent number: 12350260
    Abstract: The present invention relates to the treatment of sensory neuropathy induced by a marine neurotoxic poisoning. The invention further encompasses an in vitro method for producing a neuro-cutaneous model allowing to study the cellular and/or molecular mechanisms involved in said neuropathy, a neuro-cutaneous model obtainable according to said method, and applications thereof.
    Type: Grant
    Filed: April 5, 2020
    Date of Patent: July 8, 2025
    Assignees: Universite De Bretagne Occidentale, Centre Hospitalier Regional Et Universitaire De Brest, INSERM (Institut National de la Santé et de la Recherche Médicale)
    Inventors: Raphaele Le Garrec, Killian L'Herondelle, Laurent Misery, Ophelie Pierre, Olivier Mignen
  • PROTEASE-ACTIVATED RECEPTOR-2 INHIBITORS FOR THE TREATMENT OF SENSORY NEUROPATHY INDUCED BY A MARINE NEUROTOXIC POISONING
    Publication number: 20220193048
    Abstract: The present invention relates to the treatment of sensory neuropathy induced by a marine neurotoxic poisoning. The invention further encompasses an in vitro method for producing a neuro-cutaneous model allowing to study the cellular and/or molecular mechanisms involved in said neuropathy, a neuro-cutaneous model obtainable according to said method, and applications thereof.
    Type: Application
    Filed: April 5, 2020
    Publication date: June 23, 2022
    Inventors: Raphaele Le Garrec, Killian L'Herondelle, Laurent Misery, Ophelie Pierre, Olivier Mignen